This study was undertaken to determine the effect of dichloroacetate (DCA) on myocardial functional and metabolic recovery following global ischemia. Sixteen isolated rabbit hearts were subjected to 120 minutes of mildly hypothermie (34°C) cardioplegic arrest with multi-dose, modified St. Thomas'cardioplegia.
RESULTS
Therc wcrc no significant diffcrences at basclinc for heart ratcs. DP, or dP/dt valucs bctween control hcarts and DCA hearts. and basclinc DP averagcd 110 mmHg for ai1 hearts. Left ventricular systolic and diastolic functional mcasuremcnts of DP and dP/dt made after 45 minutes 01 repcrfusion are shown in Table 1 as percent recovery of function compared to bascline values. Diastolic stiffness (or compliancc, AEDP!AEDV) is exprcsscd as the slopc of the lint that best dcscribed the change in end-diastolic prcssure for each 0.1 mL change in end-diastolic volume.
After 120 minutcs of hypothermie ischemia and 45
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(+)dP/dl :-)dPidI minutes of reperfusion, control hcarts recovered 37 -t X% of baselinc DP and 43 ? 10% of baseline dP/dt (Fig 3) . Hearts reperfused with DCA showcd significantly better recovery of function, to 62 rt 4% of baselinc DP and 67 * 5% of baselinc dP/dt (P < 0.05 versus control hearts).
Diastolic stiffness was significantly improved in hearts reperfused with DCA compared to CON (Fig 4) . Aftcr 45 minutes of repcrfusion.
thc control hearts were characterizcd by a higher diastolic stiffness slopc value of 156.7 (a 15.6 2 0.8 mmHg risc in EDP for cach 0.1 mL incrcasc in EDV) versus a diastolic stiffness value of 82.6 5 I 1 in those hcarts reperfused with DCA (P < 0.05).
Myocardial
metabolic
indices are shown in Tablc 2. Coronary blood flow was nat different between control hcarts and these reperfuscd with DCA at basclinc or at any time during reperfusion.
Bascline valucs were 41 i Y mL/min and 38 ? 5 mlimin in the CON and DCA hearts. respectivcly.
and 38 ? 12 and 29 c 7 at 45 minutes of reperfusion. Myocardial oxygen consumption was not diffcrent bctween groups at baseline but was increased in DC'A rcperfused hearts versus control hcarts at 45 minutes of reperfusion (Fig 5) . Basclinc MCO, was 63 rr 10 mligimin and 67 rc 10 mL/g/min in control and DCA hearts. rcspcctively, and at 45 minutes of rcperfusion was 32 -t 11 in control versus 48 + 12 in DCA hcarts (P < 0.05). Likewisc. %O, extraction was not different betwccn groups The change in intramyocardial pH during rcperfusion was not different between control hearts and thosc receiving DCA as measured by this technique (Fig 6) .
DISCUSSION
These results indicate that DCA administration during reperfusion significantly improves myocardial functional and metabolic recovery following cold, cardioplegic global ischemia. The mechanism of this enhanced recovery may bc dut either to metabolic alterations or inotropic support of thc reperfused myocardium.
Myocardial ischemia and the etfcct of reperfusion have been extensivcly studied, often using isolated hcart preparations. These preparations are uscful in that metabolic processes can bc manipulated in a wide variety of ways and the effect of such manipulation on functional recovery studied. There are scveral types of global ischemic models in thc literaturc: (1) warm, working global ischemia with ncither substrate nor oxygen supplied, (2) warm working global anoxia with substratc perfusion, (3) cold cardioplegic arrest with neithcr substratc nor oxygen supplied. Thc fìrst two rcprescnt thc conditions of suddcn death or cardiac REFl&lJsm arrest (myocyte nccrosis), whereas the latter mimics the conditions of thc heart during bypass or the heart harvested for transplantation (myocyte stunning). The ability of the myocardial ccll to recover functionally following an ischcmic insult is variable, depending on the duration of the ischemia and the mctabolic conditions existing prior to, during, and aftcr ischemia. Although thc final pathway for recovery appears to be rcpletion of high-energy phosphate or ATP levcls, it is not yet certain which conditions before or after ischcmia enable thc cel] to restore energy levels to normal during rcperfusion. Factors that appear to diminish the ccll's ability to regenerate ATP include decreased availability of adenosine nucleotides,O-y Ca+ + levels,'OJ1 and the accumulation of glycolytic mctabolites, including laclate, H+. NADH, and oxygen free radicals."-IJ Ender normal metabolic conditions. the metabolism of frcc fatty acids providcs nearly 70% of the high-energy phosphate bonds required for normal function.14 Following a period of hypoperfusion or total global ischemia, the myocardial cell is critically dcpendent on glycolysis for functional recovery during reperfusion.'"J During ischemia, as the supply of cellular oxygen diminishes, electron flux through the electron transport chain falters and as NADH accumulates, oxidative phosphorylation ceases. Tbe consequent decreasc in ATP levels directly stimulates 
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dia1 pH returned to 7.2 within 2 minutes of reperfusion in both control and DCA hcarts, most likely due to rapid washout of anaerobic byproducts with a pH-baianced reperfusion solution. Therefore, the improvcd functional recovery secn with DCA in this model cannot bc simply ascrihcd to amelioration of acidosis. DCA may also have inotropic propcrtics. When studicd in a model of endotoxin-shocked rat hearts without ischemia, DCA enhanced the inotropic effect of both amrinone and ouabain and indcpendently increascd glucose oxidation in these hearts. ' The enhanced oxygen consumption noted with DCA administration could bc cithcr cause or effect of improved function. An incrcasc in myocardial mechanica1 use efficiency was found, ie, the amount of work done per milliliter of oxygen consumed, in hcarts rcpcrfuscd with DCA. This interesting effect has been notcd in othcr studies of DCA, including one performed in 9 patients with known coronary artery discase,': and in a study of hypoxic lactic acidosis in dogs.lx An improvcmcnt in both myocardial function and oxygen use during DCA administration were noted, but can only bc speculatcd whcther the myocardial functional recovery it notcd was dut to a direct inotropic effect of DCA, due to enhanccd oxidative phosphorylation and ATP replction during rcpcrfusion, or rcsulted from an altered myocardial oxygcn usc.
In summary, DCA is a promising new agent capable of cnhancing myocardial functional recovery and improving mechanica1 use efficiency when administered following induced global ischcmia. but further study will be rcquired to delincate thc exact nature of its bcnctïcial effect.
